Asuragen launches InformThyroid, a panel of molecular markers Asuragen, Inc. The FNAs are analyzed in Asuragen’s CAP certified CLIA Laboratory. The Revised American Thyroid Association Administration Guidelines for Sufferers with Thyroid Differentiated and Nodules Thyroid Malignancy has stated, The usage of molecular markers could be considered for individuals with indeterminate cytology on FNA to greatly help guide administration.D., CEO. Biocell Middle has been dealing with perinatologists and Ob/Gyn doctors world-wide for quite some time, stated Kate Torchilin, CEO of Biocell Center Company.June 30 For the half a year ended, 2011, income increased 48 percent to $21,968. Income for physiotherapy services rendered through our Eldercare and Homecare divisions was $11,253 for the three month period ended June 30, 2011, a 54 percent boost of the same period in the prior year. Eldercare added 4,287 brand-new beds in its existing business in the six month period ended June 30, 2011, which includes contributed growth of $1,853. Income for Surgical and Medical providers in the period was $5,498, january 1 a significant increase from the last year resulting from the SSI acquisition effective, 2011.